Expression of somatostasin receptors in arginine vasopressin hormone-secreting olfactory neuroblastoma - Report of two cases

Rhinology

Volumn 43, Issue 1, 2005, Pages 61-65

  Freeman, S R M ^a   Mitra, S ^a   Malik, T H ^a   Flanagan, P ^b   Selby, Peter ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b ROYAL CORNWALL HOSPITAL   (United Kingdom)

Author keywords

Esthesioneuroblastoma; Octreotide; Radiographic scintography; SIADH; Syndrome of inappropriate antidiuretic hormone

Indexed keywords

ARGIPRESSIN; OCTREOTIDE; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CRANIOFACIAL SURGERY; ESTHESIONEUROBLASTOMA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HORMONE RELEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INAPPROPRIATE VASOPRESSIN SECRETION; PROTEIN EXPRESSION; TUMOR DIAGNOSIS; TUMOR SCINTISCANNING; BIOSYNTHESIS; METABOLISM; MIDDLE AGED; NOSE CAVITY; NOSE TUMOR; SECRETION;

ADULT; ARGININE VASOPRESSIN; ESTHESIONEUROBLASTOMA, OLFACTORY; FEMALE; HUMANS; MIDDLE AGED; NASAL CAVITY; NOSE NEOPLASMS; RECEPTORS, SOMATOSTATIN;

EID: 17044368804     PISSN: 03000729     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Broich G, Pagliari A, Ottaviani F (1997) Esthesioneuroblastoma: a general review of the cases published since the discovery of the turmour in 1924. Anticancer Research 17: 2683-2706.
2. Ramsay H, Kairemo K, Jekunen A (1996) Somatostatin receptor imaging of olfactory neuroblastoma. J Laryngol Otol 110: 1161-1163.
3. Miller K (1996) Immunocytochemical techniques. In: JD Bancroft, A Stevens (Eds.) Theory and practice of histological techniques (edn 4). Churchill Livingstone, New York, USA, pp. 435-470.
4. Taxy JB, Bharani NK, Mills SE, Frierson HF, Gould VE (1986) The spectrum of olfactory neural tumors: a light-microscopic immunohistochemical and ultrastructural analysis. American Journal of Surgical Pathology 10: 687-695.
5. Silva EG, Butler JJ, Mackay B, Goepfert H (1982) Neuroblastoma and neuroendocrine carcinomas of the nasal cavity: a proposed classification. Cancer 50: 2388-2405.
6. Ordonez NG, Mackay B (1993) Neuroendocrine tumors of the nasal cavity. Pathology Annual 28: 77-111.
7. Hirose T, Scheithauer BW, Lopes MBS, Gerber HA, Altermatt HJ, Harner SG, VandenBerg SR (1995) Olfactory neuroblastoma: an immunohistochemical, ultrastructural, and low cytometric study. Cancer 76: 14-19.
8. Bombardieri E, Maccauro M, de Deckere E, Savelli G, Chiti A (2001) Nuclear medicine imaging of neuroendocrine tumours. Annals of Oncology 12: S51-S61.
9. Woodhead P, Lloyd GAS (1988) Olfactory neurobastoma: imaging by magnetic resonance, CT and conventional techniques. Clin Otolaryngol 13: 387-394.
10. Li C, Yousem DM, Hayden RE, Doty RL (1993) Olfactory neuroblastoma: MR evaluation. AJNR 14: 1167-1171.
11. Schuster JJ, Phillips CD, Levine PA (1994) MR of esthesioneuroblastoma (olfactory neuroblastoma) and appearance after craniofacial resection. AJNR 15: 1169-1177.
12. Pickuth D, Heywang-Kobrunner SH, Spielmann RP (1999) Computed tomography and magnetic resonance imaging features of olfactory neuroblastoma: an analysis of 22 cases. Clin Otolaryngol 24: 457-461.
13. Levine PA, Gallagher R, Cantrell RW (1999) Esthesioneuroblastoma: reflections of a 21-year experience. Larynoscope 109: 1539-1543.
14. Dulguerov P, Allal AS, Calcaterra TC (2001) Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol 2: 683-690.
15. Slevin N, Irwin C, Banerjee S, Gupta N, Farrington W (1996) Olfactory neural tumours- the role of external beam radiotherapy. J Laryngol Otol 110: 1012-1016.
16. Fitzek MM, Thornton AF, Varvares M, Ancukiewicz M, Mcintyre J, Adams J, Rosenthal S, Joseph M, Amrein P (2002) Neuroendocrine tumours of the sinonasal tract. Cancer 94: 2623-2634.
17. Hejna M, Schmidinger M, Raderer M (2002) The clinical role of somatostatin analogues as antineoplastic agents: much ado about nothing? Ann Oncol 13: 653-668.